Gnosis (GNO) merits a Hold rating based on mixed, mostly range-bound evidence. The 24-hour price is down 0.47% at $119.70 and sits in the lower portion of its $119.09–$121.37 range, indicating modest near-term weakness but not, by itself, a decisive trend signal.

The hourly moving averages give a slightly bearish near-term picture: price is below the 13-, 21-, and 55-hour averages of $119.77, $120.17, and $120.88, respectively. It is just above the 8-hour average at $119.63 and the 144-hour average at $119.47, so the averages are mixed and clustered near the current price rather than showing strong directional separation.

The 1-hour RSI of 33 signals weak short-term momentum and is close to, but not below, the conventional 30 oversold threshold. That could leave room for a rebound, but it does not confirm one; the 7-day RSI of 51 is neutral and provides no strong broader momentum signal.

Performance across measured periods is also mixed. GNO is down 0.42% over seven days, while it is up 3.07% over 14 days and 1.09% over 30 days, suggesting modest gains over the longer windows but little net progress recently.

The 24-hour volume is 1,272,235, and volume-to-market-cap is 0.40%. These figures describe activity but do not establish whether buying or selling pressure is dominant, so they provide limited confirmation for either a bullish or bearish conclusion.

At $119.70, GNO is about 81% below its $644.20 all-time high. That is relevant historical context, but the supplied data do not show that the former high is a current price target or that it provides a basis for predicting a recovery.

Overall, the evidence supports Hold rather than Buy or Sell: neutral 7-day RSI and positive 14- and 30-day changes offset the weak daily move, low-end daily positioning, and price below several hourly averages. The primary reason to avoid a stronger rating is the absence of a clear, consistent trend signal; short-term weakness is real, but the broader supplied measures do not confirm sustained downside.